Targeting PKGIα Cys42 attenuat... Note

Targeting PKGIα Cys42 attenuates cardiac dysfunction in heart failure with preserved ejection fraction | Science Advances

Heart failure with preserved ejection fraction (HFpEF) is a highly prevalent condition associated with substantial morbidity and mortality, yet effective therapeutic options remain limited. As oxidation of Cys42 in cyclic guanosine monophosphate (cGMP)-...
CdXz5zHNQW_l0s7ThDGQf.jpeg